Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Atlantica Sustainable Infrastructure | AY | Sep 19, 2024 | 21.89 | -0.14 |
Atlanticus | ATLC | Sep 19, 2024 | 35.55 | +3.10 |
Atlanticus B Pref | ATLCP | Sep 19, 2024 | 22.88 | +0.35 |
Atlas Energy Solutions | AESI | Sep 19, 2024 | 22.28 | +2.63 |
Atlas Lithium | ATLX | Sep 19, 2024 | 7.91 | -16.17 |
Atlas Pref D | ATCO-D | Sep 19, 2024 | 25.45 | +0.99 |
Atlas Pref H | ATCO-H | Sep 19, 2024 | 25.30 | +0.84 |
AtlasClear Holdings | ATCH | Sep 19, 2024 | 0.18 | +27.53 |
Atlassian A | TEAM | Sep 19, 2024 | 163.10 | +2.04 |
Atmos Energy | ATO | Sep 19, 2024 | 136.25 | -0.21 |
Atmus Filtration Technologies | ATMU | Sep 19, 2024 | 36.72 | +3.12 |
ATN International | ATNI | Sep 19, 2024 | 29.95 | +2.50 |
Atomera | ATOM | Sep 19, 2024 | 2.70 | +4.65 |
Atossa Therapeutics | ATOS | Sep 19, 2024 | 1.46 | +2.82 |
Atour Lifestyle ADR | ATAT | Sep 19, 2024 | 21.25 | +4.42 |
ATRenew A ADR | RERE | Sep 19, 2024 | 2.19 | -3.95 |
AtriCure | ATRC | Sep 19, 2024 | 28.81 | +2.93 |
Atrion | ATRI | Sep 19, 2024 | 459.92 | 0.00 |
ATS Corporation | ATS | Sep 19, 2024 | 28.45 | +5.53 |
aTyr Pharma | ATYR | Sep 19, 2024 | 1.87 | +2.75 |
Auburn National Bank | AUBN | Sep 19, 2024 | 20.56 | +3.58 |
Auddia | AUUD | Sep 19, 2024 | 0.79 | -0.25 |
AudioCodes | AUDC | Sep 19, 2024 | 9.11 | -0.98 |
AudioEye | AEYE | Sep 19, 2024 | 23.43 | +9.59 |
Augmedix | AUGX | Sep 19, 2024 | 2.33 | 0.00 |
Ault Alliance | AULT | Sep 19, 2024 | 0.21 | 0.00 |
Ault Disruptive Technologies SPAC | ADRT | Sep 19, 2024 | 12.01 | -3.60 |
Auna S.A.A | AUNA | Sep 19, 2024 | 7.46 | +0.13 |
Aura Biosciences | AURA | Sep 19, 2024 | 9.69 | +1.47 |
Aura FAT Projects Acquisition A | AFAR | Sep 19, 2024 | 11.68 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.